Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after Acute Kidney Injury among Veterans with Diabetic Kidney Disease.
Daniel P MurphyJulian A WolfsonScott ReuleKirsten L JohansenAreef IshaniPaul E DrawzPublished in: Kidney360 (2024)
SGLT2i use was associated with a lower risk for CKD progression and for recurrent AKI among those with diabetic kidney disease and recent AKI.